CrossCoat Medical Overview
- Status
- Private
- Employees
- 3

- Latest Deal Type
- Series D
- (Cancelled)
- Latest Deal Amount
- $2M

- Investors
- 2
CrossCoat Medical General Information
Description
Developer of micro-invasive treatments designed to treat rotator cuff repair, snoring, obstructive sleep apnea, meniscus repair and wound dehiscence. The company's micro-invasive treatments offer a device that strengthens and stabilizes the tissues based on body's own natural response and heals the instability and degradation of weakened tissue, enabling patients to recover snoring and obstructive sleep apnea.
Contact Information
- 1501 Bull Lea Road
- Suite 103
- Lexington, KY 40511
- United States
CrossCoat Medical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series D) | $2M | Cancelled | Startup | |||
4. Later Stage VC (Series C) | 00.00 | 00.000 | Completed | Startup | ||
3. Angel (individual) | 03-Feb-2017 | 00000 | 00000 | Completed | Startup | |
2. Angel (individual) | 01-Dec-2014 | $425K | $425K | Completed | Startup | |
1. Grant | 01-Oct-2014 | $400K | Completed | Startup |
CrossCoat Medical Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Thomas Hedman Ph.D | Founder & Chief Scientific Officer | ||
Elsa Abruzzo | Vice President, Regulatory Affairs | ||
Lyle Hawkins | Chief Executive Officer, Board Member & President |
CrossCoat Medical Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial